味道好、没热量的糖存在吗？北京这家生物制造企业已研发

Core Insights - Synthetic biology is recognized as the "third biotechnology revolution," following the discovery of the DNA double helix and the Human Genome Project, and is becoming a focal point in global technological competition [1] - It is predicted that 70% of future products will be derived from biological methods [1] Group 1: Industry Developments - Beijing has achieved multiple breakthroughs in synthetic biology manufacturing, with applications in biomedicine, beauty economy, chemical energy, and agriculture [1] - The synthetic biology manufacturing industry in Changping District generated over 6 billion yuan in revenue last year [6] - The Changping District has gathered over 120 synthetic biology companies, with projected revenue exceeding 6 billion yuan in 2024 and fixed asset investments surpassing 4.3 billion yuan [7] Group 2: Company Innovations - Microgen Synthetic, established in December 2021, is one of the earliest teams in China engaged in synthetic biology research and industrialization [3] - The company has developed a one-step fermentation method for producing allulose, achieving over 80% conversion rate and significantly reducing production costs [4] - The company has also established an engineering scale-up center and a small-scale flexible production base in Qinhuangdao, which are now operational [5] Group 3: Technological Advancements - Synthetic biology manufacturing addresses high energy consumption and pollution in chemical production, as well as low efficiency and high costs in agricultural planting [2] - Beijing has made significant advancements in key technologies such as carbon conversion and chassis cell design, leading to innovative products like high-efficiency DNA insertion technology and bio-based adipic acid production [8]